Argenx
ARGX
#466
Rank
C$71.23 B
Marketcap
C$1,151
Share price
2.63%
Change (1 day)
26.99%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2025 (TTM): C$12.46

According to Argenx 's latest financial reports the company's current EPS (TTM) is C$12.10. In 2024 the company made an earnings per share (EPS) of C$19.00 an increase over its 2023 EPS that were of C-$7.04.

EPS history for Argenx from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$12.46-34.4%
2024C$19.00-369.77%
2023C-$7.04-60.46%
2022C-$17.8163.33%
2021C-$10.90-40.37%
2020C-$18.29183.47%
2019C-$6.45123.09%
2018C-$2.8954.93%
2017C-$1.8714.07%
2016C-$1.6413.05%
2015C-$1.45-36.34%
2014C-$2.27209.04%
2013C-$0.74-33.99%
2012C-$1.11185.59%
2011C-$0.39